Canada to eliminate regulatory delays in switching Rx drugs to OTC
This article was originally published in SRA
Executive Summary
The Canadian government has announced plans to remove a regulatory requirement that delays access to new over-the-counter drugs1. Specifically, it has decided to eliminate Schedule F of the Food and Drug Regulations to reduce delays associated with switching a drug from prescription to over-the-counter status.